COVID image

COHG-SA

Paper Detail

TitleJapan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan
DOI https://doi.org/10.1101/2021.05.17.21256513
MethodGenome wide association study
Curator 1clherd
Curator 2fatima
Population Namkoong
Published Yes
Variant detailDescription of ComparisonGeneRSIDAssociationDisease StatusMAFStatistical Odds RatioStatistical P-value
Variant Namkoong_rs13050728 COVID-19 vs control IFNAR2 rs13050728 Positive Susceptibility 0.573 1.1 1.50e-02
Variant Namkoong_rs13050728 Young COVID-19 vs control IFNAR2 rs13050728 Positive Susceptibility 0.58 1.16 2.40e-03
Variant Namkoong_rs13050728 Young severe COVID-19 vs contr IFNAR2 rs13050728 Positive Severe 0.605 1.28 3.90e-03
Variant Namkoong_rs1886814 COVID-19 vs control FOXP4 rs1886814 Positive Susceptibility 0.307 1.14 3.50e-03
Variant Namkoong_rs1886814 Severe COVID-19 vs control FOXP4 rs1886814 Positive Severe 0.317 1.29 9.10e-05
Variant Namkoong_rs1886814 Young COVID-19 vs control FOXP4 rs1886814 Positive Susceptibility 0.314 1.17 4.50e-03
Variant Namkoong_rs1886814 Young severe COVID-19 vs cntrl FOXP4 rs1886814 Positive Severe 0.34 1.42 1.20e-04
Variant Namkoong_rs210969 Severe COVID-19 vs control DPP9 rs210969 Positive Severe 0.133 1.2 3.10e-02
Variant Namkoong_rs35081325 Severe COVID-19 vs control LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3 rs35081325 Positive Severe 0.0032 7.06 9.00e-03
Variant Namkoong_rs35081325 Young severe COVID-19 vs cntrl LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3 rs35081325 Positive Severe 0.003 11.8 1.40e-02
Variant Namkoong_rs529565 Severe COVID-19 vs control ABO rs529565 Positive Severe 0.494 1.18 2.80e-03
Variant Namkoong_rs529565 Young severe COVID-19 vs cntrl ABO rs529565 Positive Severe 0.51 1.22 1.20e-02
Variant Namkoong_rs60200309 Young Meta-severity vs Control DOCK2 rs60200309 Positive Severe 0.159 2.0 2.00e-08
Variant Namkoong_rs60200309 Meta Japanese vs pan ancestry DOCK2 rs60200309 unknown Severe None 1.97 1.20e-09
Variant Namkoong_rs60200309 COVID-19 vs control DOCK2 rs60200309 Positive Susceptibility 0.119 1.24 1.10e-03
Variant Namkoong_rs60200309 Severe vs non-severe COVID-19 DOCK2 rs60200309 Positive Severe 0.08 1.27 2.80e-02
Variant Namkoong_rs60200309 Severe vs non-severe_young DOCK2 rs60200309 Positive Severe 0.08 1.9 1.10e-05
Variant Namkoong_rs60200309 Severe COVID-19 vs control DOCK2 rs60200309 Positive Severe 0.129 1.39 3.10e-04
Variant Namkoong_rs60200309 Young COVID-19 vs control DOCK2 rs60200309 Positive Susceptibility 0.123 1.32 5.10e-04
Variant Namkoong_rs60200309 Young severe COVID-19 vs cntrl DOCK2 rs60200309 Positive Severe 0.159 2.01 1.20e-08
Variant Namkoong_rs72711165 Young COVID-19 vs control TMEM65 rs72711165 Positive Susceptibility 0.04 1.31 4.00e-02
Variant Namkoong_rs77534576 Severe COVID-19 vs control TAC4, KAT7,DLX3, FLJ45513 rs77534576 Positive Severe 0.057 1.29 4.30e-02